Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Alken – page 58

1 808 clinical trials in Alken, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Alken at a glance
1 808
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 808 trials in Alken

Open in trial search

Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital

Study on Posaconazole and Fluconazole for Preventing Fungal Infections in Patients with Acute Myeloid Leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Fluconazole
  • Sponsor:Centre Hospitalier Universitaire Vaudois

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Gilead Sciences Inc.

Study on Citalopram for Patients with Reflux Hypersensitivity or Functional Heartburn Not Fully Helped by Proton Pump Inhibitors

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Citalopram
  • Sponsor:UZ Leuven

Neoplasm

Recruiting

Study on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Brigimadlin
  • Sponsor:Boehringer Ingelheim Espana S.A.

Dyspepsia

Recruiting

Study on Budesonide and Mannitol for Treating Inflammation in Patients with Functional Dyspepsia

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:UZ Leuven

Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Blinatumomab
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on Docetaxel, Cabazitaxel, and Darolutamide for Men with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cabazitaxel
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Study on Timing of Chemotherapy with Paclitaxel Albumin-Bound and Drug Combination for Patients with Metastatic Pancreatic Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Amsterdam UMC Stichting

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Colitis ulcerative+1

Recruiting

Study of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Vedolizumab
  • Sponsor:Takeda Development Center Americas Inc.

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Alken

What the registry says about research in the country

01 Respiratory & ENT Studies

Research focusing on respiratory syncytial virus (RSV) in older adults and chronic sinus conditions, evaluating novel therapeutic approaches for respiratory health.

  • RSV vaccination studies in adults 60+
  • Chronic rhinosinusitis with nasal polyps treatment

Investigating immune responses and testing new treatments for nasal congestion and polyp reduction.

02 Sleep Disorders

Comprehensive studies examining treatments for narcolepsy and sleep disturbances, with particular focus on different narcolepsy types and menopausal sleep issues.

  • Narcolepsy Type 1 and 2 therapies
  • Menopausal sleep disturbances
  • Long-term safety evaluations

Testing innovative compounds to improve excessive daytime sleepiness and related symptoms.

03 Mental Health & Neurology

Advanced research into major depressive disorder and Alzheimer's-related conditions, exploring new therapeutic approaches for complex neuropsychiatric symptoms.

  • Depression with anhedonia
  • Alzheimer's-related psychosis
  • Agitation in dementia

Evaluating novel treatments and combination therapies for better patient outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.